MPR Weekly Dose 103 - Novel treatment for insomnia; Magnesium health claim; Dental decay and transmucosal med; Vaccine and menstrual cycle findings; Best diets for 2022
This week: Novel insomnia treatment; The FDA comment on magnesium hypertension claim; Transmucosal buprenorphine linked to dental decay; Researchers assess changes in menstrual cycle in relation to CO...
13 Jan 202212min
MPR Weekly Dose 102 - COVID-19 vaccine contraindication; Final results for COVID-19 antiviral; Entadfi approved; CAR T-cell REMS change; New approval for psoriatic arthritis
Contraindication added to Janssen COVID-19 vaccine; Pfizer announce final results for their COVID-19 oral antiviral; A new treatment for benign prostatic hyperplasia; REMS change for CAR T-cell therap...
17 Des 202114min
MPR Weekly Dose 101 - COVID-19: Pre-exposure prophylaxis approved; Omicron vaccine protection; Antibody authorized for kids; Heterolous boosting assessed; Veklury recall
This week we bring you up to speed on a lot of COVID-related news, despite the emergence of Omicron, there is positive news; Evusheld has become the first pre-exposure prophylaxis for COVID-19; Data s...
10 Des 202113min
MPR Weekly Dose 100 - Paxlovid EUA submission; Drugs linked to orthostatic hypotension; Besremi approved; Pill for remote endoscopy; Largest psilocybin trial to date
We made it to 100! This week Pfizer seeks Emergency Use Authorization for their COVID oral antiviral; A meta-analysis found commonly prescribed drugs were linked to orthostatic hypotension; A novel tr...
19 Nov 202113min
MPR Weekly Dose 99 - Oral COVID-19 candidate reduces risk of death; aromatherapy sprays recalled; Presbyopia Tx; Naloxone alternative; Migraine drug head-to-head study
This week there's positive news for the COVID-19 oral antiviral candidate, Paxlovid; The CDC expands a recall for aromatherapy sprays connected to fatal cases of a rare tropical disease; The first eye...
12 Nov 202111min
MPR Weekly Dose 98 - FDA Committee Vote on Vaccines for Children; Booster Efficacy Results; Shingrix Recommendations; Novel Treatment for Macular Edema; Pepaxto Withdrawn
The FDA votes on whether the Pfizer-BioNTech vaccine should be authorized in 5 to 11 year olds; The Moderna vaccine elicits strong antibody responses in pediatrics; Trial results shed light on booster...
29 Okt 202114min
MPR Weekly Dose 97 - 'Mix and Match' Boosters Authorized; Biosimilar to Humira; Nasal Spray for Dry Eye Disease; Novel Pain Treatment; Opioid Overdose Treatment
This week: big news announced in COVID-19, with the FDA stating that mixing and matching of vaccines for the booster dose is authorized. The first interchangeable biosimilar to Humira is approved. Als...
22 Okt 202112min
MPR Weekly Dose 96 - Updated Aspirin Recommendations; Needle-Free Warning; Isotretinoin REMS program; Pediatric Athymia Tx; EU Request for Molnupiravir; Advisory Panel Votes on Moderna Booster Shot
This week the USPSTF update aspirin recommendations for those 60 years and older; The FDA take a stance on needle-free devices for injecting dermal fillers; REMS requirements are updated for isotretin...
15 Okt 202113min
